Compared with GnRH analogues, such E2 levels are not expected to cause the reactivation of endometriotic lesions, whereas they are high enough to prevent hot flashes and bone loss, which has been found during the treatment of endometriosis with DNG [38]. The gene discussed is GNRH1; the disease is endometriosis.